Cargando…

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

BACKGROUND: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel drug delivery system able to induce regression of peritoneal metastasis (PM) in the salvage situation. The aim of this study was to determine the clinical characteristics, tumor histology, and extent of disease of the pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Girshally, Ramy, Demtröder, Cedric, Albayrak, Nurettin, Zieren, Jürgen, Tempfer, Clemens, Reymond, Marc A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039790/ https://www.ncbi.nlm.nih.gov/pubmed/27678344 http://dx.doi.org/10.1186/s12957-016-1008-0

Ejemplares similares

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for the treatment of malignant mesothelioma
por: Giger-Pabst, Urs, et al.
Publicado: (2018)

Technology development of hyperthermic pressurized intraperitoneal aerosol chemotherapy (hPIPAC)
por: Bachmann, C., et al.
Publicado: (2021)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Occupational Health and Safety Aspects
por: Solaß, Wiebke, et al.
Publicado: (2013)

Renal and Hepatic Toxicities After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
por: Blanco, Ana, et al.
Publicado: (2013)

In Vivo Feasibility of Electrostatic Precipitation as an Adjunct to Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC)
por: Kakchekeeva, Tinatin, et al.
Publicado: (2016)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis
por: Nadiradze, Giorgi, et al.
Publicado: (2015)

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in a woman with pseudomyxoma peritonei: A case report
por: Tempfer, Clemens B., et al.
Publicado: (2014)

Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC)
por: Sgarbura, Olivia, et al.
Publicado: (2022)

Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge
por: Murughan, Kavita, et al.
Publicado: (2014)

Dynamic changes of tumor gene expression during repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC) in women with peritoneal cancer
por: Rezniczek, Günther A., et al.
Publicado: (2016)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer
por: Gamboa, Adriana C., et al.
Publicado: (2019)

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) as an outpatient procedure
por: Graversen, Martin, et al.
Publicado: (2018)

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for rare gynecologic indications: peritoneal metastases from breast and endometrial cancer
por: Rezniczek, Günther A., et al.
Publicado: (2020)

Hyperthermic intracavitary nanoaerosol therapy (HINAT) as an improved approach for pressurised intraperitoneal aerosol chemotherapy (PIPAC): Technical description, experimental validation and first proof of concept
por: Göhler, Daniel, et al.
Publicado: (2017)

Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy for recurrent adult granulosa cell tumor: A case report
por: Dogan, Askin, et al.
Publicado: (2016)

Anaesthesia considerations and techniques for Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC)
por: Shree, Venkatesan, et al.
Publicado: (2020)

Experiences with cytoreduction surgery plus hyperthermic intraperitoneal chemotherapy in Taiwan
por: Hsieh, Mao-Chih, et al.
Publicado: (2017)

Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?
por: Leigh, Natasha, et al.
Publicado: (2020)

Single-Port Laparoscopic Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
por: Alshammari, Turki, et al.
Publicado: (2019)

Anesthetic concerns during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
por: Ryu, Jung-Hee, et al.
Publicado: (2021)

Temperature management during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
por: Ramirez, Maria F., et al.
Publicado: (2023)

Urgent re-laparotomies in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Manoğlu, Berke, et al.
Publicado: (2022)

Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
por: Pintado, Maria Consuelo, et al.
Publicado: (2023)

Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy
por: Solass, Wiebke, et al.
Publicado: (2013)

Cytoreductive onco-surgery with combined hyperthermic intraperitoneal chemotherapy and hyperthermic intrathoracic chemotherapy: Perioperative challenges
por: Dattatri, Rohini, et al.
Publicado: (2019)

Overcoming Drug Resistance by Taking Advantage of Physical Principles: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
por: Nadiradze, Giorgi, et al.
Publicado: (2019)

Current Medical Care Situation of Patients in Germany Undergoing Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
por: Horvath, Philipp, et al.
Publicado: (2022)

Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study
por: Leimkühler, M., et al.
Publicado: (2019)

Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study
por: Kurtz, Florian, et al.
Publicado: (2018)

Is Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) Effective in Ovarian Cancer With Peritoneal Metastasis?
por: Mohammad, Amad, et al.
Publicado: (2022)

Pregnancy after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei
por: Campanati, Renato Gomes, et al.
Publicado: (2014)

Wernicke encephalopathy as rare complication of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Macrì, Antonio, et al.
Publicado: (2015)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Fluid and temperature remain the culprit!
por: Garg, Rakesh
Publicado: (2018)

Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Mercier, F., et al.
Publicado: (2018)

Intraoperative metabolic changes associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Rubio-López, Jesús David, et al.
Publicado: (2023)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases in Solid Organ Graft Recipients: First Experience
por: Horvath, Philipp, et al.
Publicado: (2019)

Management of peritoneal surface metastases from colorectal cancer: Cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, pressurized intraperitoneal chemotherapy, and beyond
por: Mangieri, Christopher W., et al.
Publicado: (2022)

Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells
por: Khosrawipour, Veria, et al.
Publicado: (2017)

Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy – PIPAC-OPC2
por: Graversen, Martin, et al.
Publicado: (2018)

Comparison between microcatheter and nebulizer for generating Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
por: Toussaint, Laura, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5ejr80vri0shr3gn7dqi0t24rm